Cancer cells can evade T-cell detection—diminished activation
and proliferation of cancer-specific T cells result in the limited
ability of T cells to attack cancer cells

With CAR T technology, a patient’s immune system
has the potential to target cancer cells

Cancer cells can evade T-cell detection
  • Deficient in number1
  • Cannot recognize
    cancer cells
    as foreign1

With CAR T technology, your patient’s immune system has the potential to treat cancer
  • Expand in vivo1
  • Designed to recognize and attack cancer cells1
Reference: 1. Sharpe M, Mount N. Dis Model Mech. 2015;8(4):337-350.